Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02192866 · ClinicalTrials.gov registry record
Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies
A clinical trial of Peanut Allergies and Tree Nut Allergies, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 270
- Enrollment target
- 1
- Study location
NCT02192866: Recruiting study of Peanut Allergies and Tree Nut Allergies, sponsored by University of Colorado, Denver.
NCT02192866 is a study of Peanut Allergies and Tree Nut Allergies that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 270 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02192866, a study of Peanut Allergies and Tree Nut Allergies, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
Food allergies are now a major problem. These experiments involve getting blood from people with food allergies and from people without food allergies. The blood collected will be used to answer questions and find information about peanut and other food allergies. Samples will come from: * People signed up by the investigators at the University of Colorado Denver * University of North Carolina, Massachusetts General Hospital, Children's Hospital of Colorado and the Immune Tolerance Network (Benaroya Research Institute) where people have been treated for peanut allergies * University of North Carolina, Massachusetts General Hospital, National Jewish Health and The Children's Hospital in Denver where people have taken part or will take part in clinically indicated oral food challenges. Blood and health histories from the University of North Carolina, Massachusetts General Hospital, National Jewish Health, The Children's Hospital and the Immune Tolerance Network will not have personal information linked. The specific aims of this experiment are: 1. Come up with a lab test that will predict how bad an allergic reaction will be to peanuts. 2. Find out what part of a peanut causes allergic reactions. 3. Come up with preventions that can block peanut allergies. 4. Find the strongest proteins in walnuts.
Primary Outcome
This is an observational study, to describe traits (identified through blood tests) associated with severe food allergy, particularly peanut allergy.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado School of Medicine - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2014-02 |
| Est. Completion | 2030-12 |
What NCT02192866 shows while recruiting
NCT02192866 is an observational study that tracks outcomes without assigning an intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Peanut Allergies appearing as the primary indexed condition, and to 0 interventions.
NCT02192866 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02192866 about?
NCT02192866 is a clinical study titled "Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies". Food allergies are now a major problem. These experiments involve getting blood from people with food allergies and from people without food allergies. The blood collected will be used to answer questions and find information about peanut and other food allergies. Samples will come from: * People ...
What is the current status of trial NCT02192866?
This trial is currently recruiting. The enrollment target is 270 participants. The study started on 2014-02. Estimated completion is 2030-12.
What conditions does trial NCT02192866 study?
This clinical trial studies the following conditions: Peanut Allergies, Tree Nut Allergies, Other Food Allergies.
Who is sponsoring clinical trial NCT02192866?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02192866 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peanut Allergies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia